Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 5, 2011, Pages 588-597

  Fujita, Takuo ^a,b   Ohue, Mutsumi ^a   Nakajima, Mikio ^a   Fujii, Yoshio ^b   Miyauchi, Akimitsu ^c   Takagi, Yasuyuki ^d  

^a Katsuragi Hospital   (Japan)

^b Calcium Research Institute   (Japan)

^c Miyauchi Medical Clinic   (Japan)

^d National Hospital Organization Hyogo Chuo National Hospital   (Japan)

Author keywords

Elcatonin; Electroalgometry (fall of skin impedance); Pain; Risedronate; SF 36

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; CALCIUM; CREATININE; ELCATONIN; PHOSPHORUS; RISEDRONIC ACID;

AGED; ALGOMETRY; ANALGESIC ACTIVITY; ARTICLE; BACKACHE; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIZZINESS; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROALGOMETRY; EXERCISE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; NAUSEA; PAIN ASSESSMENT; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SHORT FORM 36; SKIN CONDUCTANCE; SPONDYLOSIS; UNSPECIFIED SIDE EFFECT; VISUAL RATING SYSTEM;

AGED; BACK PAIN; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; ETIDRONIC ACID; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSTEOPOROSIS; PAIN; QUALITY OF LIFE;

EID: 83155180682     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-011-0259-7     Document Type: Article

References (26)

1. Fujita T, Fujii Y, Okada SF, Miyauchi A, Takagi Y (2001) Fall of skin impedance and bone and joint pain. J Bone Miner Metab 19:175-179 (Pubitemid 32499808)
2. Fujita T, Fujii Y, Okada SF, Miyauchi A, Takagi Y (2001) Analgesic effect of etidronate on degenerative joint disease. J Bone Miner Metab 19:251-256 (Pubitemid 32681383)
3. Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi M (2009) Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. J Bone Miner Metab 27:234-239
4. Fujita T, Fujii Y, Munezane H, Ohue M, Takagi Y (2010) Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis. J Bone Miner Metab 28:477-484. doi:101007/S00774-009- 0155-6
5. Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Shea B, Wells G, Adachi J, Waldegger L, Guyatt G, Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev 23:540-551 (Pubitemid 34925648)
6. Pun KK, Chan LW (1989) Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther 11:205-209 (Pubitemid 19143364)
7. Karsdal MA, Tanko LB, Riis BJ, Sondergard BC, Henriksen K, Altman RD, Qvist P, Christiansen C (2006) Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA? Osteoarthr Cartil 14:617-624 (Pubitemid 43842738)
8. Karsdal MA, Sondergaard BC, Arnold M, Christiansen C (2007) Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann N Y Acad Sci 1117:181-195 (Pubitemid 350191278)
9. Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, Valent DJ, Meyer JM (2005) Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN 01928173]. Arthritis Res Ther 7:625-633
10. Bingham CO III, Buckland-Wright JC, Grnero P, Cohen SB, Dougados M, Adami S, Clauw DJ, Spector TD, Pelletier JP, Raynauld JP, Strand V, Simon LS, Meyer JM, Cline GA, Beary JF (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54:3494-3507 (Pubitemid 44737161)
11. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
12. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K (1998) Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51:1037-1044 (Pubitemid 28527159)
13. Fukuhara S, Were JE Jr, Kosinski M, Wada S, Gandek B (1998) Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 51:1045-1053 (Pubitemid 28527160)
14. Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2003) Intraindividual variation in lumbar bone mineral density as a measure of spondylotic deformity in the elderly. J Bone Miner Metab 21:98-102 (Pubitemid 41184308)
15. Nathan H (1962) Osteophytes of the vertebral column: an anatomical study of their development according to age, race, and sex with considerations as to their etiology and significance. J Bone Joint Surg Am 44:243-268
16. Kellgren JH, Jeffrey MR, Ball J (eds) (1963) Atlas of standard radiographs of arthritis, vol 2. The epidemiology of chronic rheumatism. Blackwell, Oxford, pp 1-23
17. Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2008) Analgesic and chondroprotective effects of risedronate in osteoarthritis assessed by electroalgometry and measurement of collagen type II fragments in urine. J Int Med Res 36:932-941
18. Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, Lyritis PG (1997) Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebocontrolled clinical study. Acta Orthop Scand Suppl 275:112-114 (Pubitemid 27485184)
19. Lyritis GP, Ioannidis GV, Karachalios T, Roidis N, Kataxaki E, Papaioannou N, Kaloudis J, Galanos A (1999) Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double- blind, randomized, placebo-controlled clinical study. Clin J Pain 15:284-289 (Pubitemid 30004887)
20. Ito A, Kumamoto E, Takeda M, Takeda M, Shibata K, Sagai H, Yosimura M (2000) Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin: participation of 5-HT1Alike receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord. J Neurosci 20:6302-6308 (Pubitemid 30658426)
21. Orimo H, Fujita T, Yoshikawa M, Watanabe S, Otani M (1972) Ultimobranchial calcitonin of the eel, Anguilla japonica. Endocrinol Jpn 19:299-302
22. Yoshikawa S, Shiba M, Hoshino T, Igarashi M, Orimo H, Sakuma A, Tsuyama N (1983) Effect of eel calcitonin derivative (elcatonin) in osteoporosis. Nippon Seikeigeka Gakkai Zasshi 57:1717-1728 (Pubitemid 14162330)
23. Fujita T, Fujii Y, Nakamura T, Miyauchi A, Takagi Y (2000) Effect of avicatonin (chicken carbocalcitonin) on galvanic skin response: a randomized, prospective, double-blind, controlled study for an objective assessment of pain. Calcif Tissue Int 66:243-247 (Pubitemid 30151794)
24. Yoh K, Tanaka K, Ishikawa A, Ishibashi T, Uchino Y, Sato Y, Tobinaga M, Hasegawa N, Kamae S, Yoshizawa M (2005) Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatment. J Bone Miner Metab 23:167-173 (Pubitemid 40591041)
25. Ohbayashi H (2009) Examination of beneficial effects of risedronate in improving quality of life during long-term treatment of primary osteoporosis. Nippon Rinsho 67:206-212. doi:10.1007/ s00774 (in Japanese)
26. Kamatari M, Koto S, Ozawa N, Urao C, Suzuki Y, Akasaka E, Yanagimoto K, Sakota K (2007) Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab 25:302-309 (Pubitemid 47283269)